Inventor · disambiguated record
Krzysztof Chwalisz
Also filed as: CHWALISZ KRZYSZTOF
25 granted patents·1 pending application·759 citations·filing 1988–2002
97Inventor score
Top patents by PatentIndex Score
26 records- 0191US5595970ATreatment of climacteric disorders with nitric oxide synthase substrates and/or donorsSCHERING AG·Filed 1993·Granted Jan 21, 1997·97 cites·14 claims
- 0289US6040340AImplantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitorsSCHERING AG·Filed 1996·Granted Mar 21, 2000·86 cites·27 claims
- 0381US5273971A13-alkyl-11β-phenylgonanesSCHERING AG·Filed 1989·Granted Dec 28, 1993·26 cites·9 claims
- 0478US7704983B1Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraceptionEASTERN VIRGINIA MED SCHOOL·Filed 1993·Granted Apr 27, 2010·55 cites·41 claims
- 0578US5244886A11β-phenyl-14βH steroidsSCHERING AG·Filed 1989·Granted Sep 14, 1993·27 cites·16 claims
- 0677US5446036A13-alkyl-11beta-phenylgonanesSCHERING AG·Filed 1993·Granted Aug 29, 1995·32 cites·10 claims
- 0775US4888331ACoadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor inductionSCHERING AG·Filed 1988·Granted Dec 19, 1989·20 cites·19 claims
- 0874US5132299A11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing sameSCHERING AG·Filed 1988·Granted Jul 21, 1992·21 cites·11 claims
- 0970US5895783ATreatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donorSCHERING AG·Filed 1993·Granted Apr 20, 1999·34 cites·22 claims
- 1067US5426102A14β-H-, 14-and 15-En-11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Jun 20, 1995·20 cites·3 claims
- 1166US5843931A6,7-modified 11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Dec 1, 1998·21 cites·4 claims
- 1264US5397344AMethods of and apparatus for measuring uterine electrical and mechanical activitySCHERING AG·Filed 1992·Granted Mar 14, 1995·99 cites·15 claims
- 1363US5965529ATreatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donorUNIV TEXAS·Filed 1995·Granted Oct 12, 1999·20 cites·32 claims
- 1455US5991649AMethods for activating the muscle cells or nerves of the uterus or cervixUNIV TEXAS·Filed 1996·Granted Nov 23, 1999·92 cites·31 claims
- 1551US6356777B1Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervixSCHERING AG·Filed 1998·Granted Mar 12, 2002·56 cites·24 claims
- 1648US5962413ATreatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitorSCHERING AG·Filed 1997·Granted Oct 5, 1999·10 cites·11 claims
- 1748US2002169205A1Implantation rates after in vitro fertilization, and treatment of infertility and early pregnancy loss with a nitric oxide donor or substrate alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors in combination with antiprogestins or other agentsFiled 2002·Application pending·0 cites
- 1844US5948762ATreatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitorSCHERING AG·Filed 1997·Granted Sep 7, 1999·7 cites·10 claims
- 1943US5519027AD-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1991·Granted May 21, 1996·5 cites·7 claims
- 2041US4891368AUse of antigestagens for softening the nonpregnant cervixSCHERING AG·Filed 1988·Granted Jan 2, 1990·3 cites·10 claims
- 2140US5795881ACombined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane typeSCHERING AG·Filed 1995·Granted Aug 18, 1998·7 cites·31 claims
- 2237US6844320B1Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donorUNIV TEXAS·Filed 1998·Granted Jan 18, 2005·3 cites·5 claims
- 2337US5744464AAntigestagens for the inhibition of uterine synthesis of prostaglandinSCHERING AG·Filed 1993·Granted Apr 28, 1998·2 cites·23 claims
- 2435US5522877AMethods for measuring uterine electrical and mechanical activitySCHERING AG·Filed 1995·Granted Jun 4, 1996·15 cites·19 claims
- 2533US5958878ATreatment of climacteric disorders with nitric oxide synthase substrates and/or donorsSCHERING AG·Filed 1995·Granted Sep 28, 1999·1 cites·34 claims
- 2629US5418227A14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienesSCHERING AG·Filed 1992·Granted May 23, 1995·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Krzysztof Chwalisz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →